InvestorsHub Logo
Followers 134
Posts 3748
Boards Moderated 0
Alias Born 01/28/2006

Re: petemantx post# 309466

Thursday, 07/09/2020 1:56:29 PM

Thursday, July 09, 2020 1:56:29 PM

Post# of 403061
My review of Covid 19 pharmaceuticals shows Brilacidin is unique. Now that preclinical trials have confirmed its Covid19 potential,IMO funding and clinical trials will be announced in a few weeks.

We desparately need therapies for Covid due to the increase in the number of cases. IMO the death rate is going to head up again soon.

With the ABSSSI trial showing Brilacidin safety in 500 patients there is no tenable reason to believe it will not do well in the clinical trials.

If we had a few hundred of Gilead's lobbyists we could be at double digit share price and be enrolled in several clinical trials.

Even though it seems things are moving in slow motion, Brilacin has made good progress. I think it is in the shareholders best interest to postpone any deals until after the first clinical trial is completed.

Time will tell. All IMO

Glta Farrell
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News